Ceftizoxime in the treatment of infections in patients with cancer.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015296:Ceftizoxime; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D009504:Neutrophils; D011014:Pneumonia / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy
D015296:Ceftizoxime; D002439:Cefotaxime